Clinical trial Recruiting at 1 site Observational Ages 18 and up

AI-based EEG for better stroke and post-cardiac arrest outcomes

Official title: AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography (SMART-EEG)

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT07886957 · Data updated 2026-11-12

Researchers are testing whether a simple subhairline EEG patch plus AI can help predict outcomes after cardiac arrest and detect brain bleeds in stroke patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment825 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedMarch 26, 2026
Main results expectedMarch 26, 2028
Study endsMarch 26, 2028
Registry record updatedOctober 21, 2026
Trial IDNCT07886957 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with postanoxic coma after cardiac arrest admitted to ICU, or adults with suspected stroke/SAH presenting to the emergency department within defined time windows.

Probably not a fit

Patients without access to or suitable for EEG monitoring, or those outside the specified time windows, may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study develops AI algorithms that analyze subhairline EEG data to predict neurological outcomes in adults with postanoxic coma after cardiac arrest and to detect intracranial hemorrhage in adults with suspected stroke or SAH. Participants will receive a continuous subhairline EEG patch in addition to standard care EEG where applicable. The study aims to validate AI models for outcome prediction at around 24 hours after cardiac arrest and for hemorrhage detection using EEG and clinical information. The approach seeks to enable faster, noninvasive assessment in critical care and emergency settings.

Why it matters

Potential benefit: If successful, the AI-driven subhairline EEG approach could provide rapid, noninvasive insights to guide early treatment decisions in ICU and ED patients.

How similar studies have gone: Pilot data suggest subhairline EEG is a feasible alternative to scalp EEG and that AI interpretation may offer rapid decision support, but broader validation is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All participants:

\- Age 18 years or older

Postanoxic coma (ICU):

* Postanoxic coma after cardiac arrest, admitted to the intensive care unit
* No objection to participation within 4 weeks of receiving an opt-out information letter

Suspected stroke (emergency department):

* Suspected stroke as assessed by the ambulance personnel presenting the patient to the emergency department, or confirmed stroke.
* Symptom onset, or last seen well if onset was not witnessed, less than 24 hours ago.
* Written (deferred) informed consent by the patient or legal representative

Suspected subarachnoid hemorrhage (emergency department):

* Suspected subarachnoid hemorrhage as judged by the attending ambulance paramedic, or confirmed subarachnoid hemorrhage.
* Symptom onset, or last seen well if onset was not witnessed, less than 48 hours ago.
* Written (deferred) informed consent by the patient or legal representative.

Exclusion Criteria:

All participants:

\- (Suspected) skin damage or infection at the placement area of the subhairline EEG patch

Postanoxic coma (ICU):

\- Other types of severe brain injury, either pre-existing or coinciding with cardiac arrest. These include stroke, traumatic brain injury and progressive neurodegenerative disease.

Where it's running

  • Amsterdam University Medical Center
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Metabolomics biomarkers to predict outcomes after subarachnoid hemorrhage

    This study tests whether blood and CSF biomarkers, together with clinical data, can predict recovery a year after spontaneous subarachnoid hemorrhage in adults treated in Lisbon.

    Recruiting Unidade Local de Saude Sao Jose · Lisbon, Lisbon District · NCT07865182

  • Recovery after coma from serious brain injury or illness

    This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.

    Recruiting University of California, San Francisco · San Francisco, California · NCT07614074

  • STRATAFIX sutures for closing cranial and spine surgical wounds

    This project will test STRATAFIX sutures for closing cranial and spine surgical wounds in adults to learn about long-term safety and healing.

    Recruiting Phase 4 University of Michigan · Lansing, Michigan · NCT07225101

  • One-stop approach for rapid start of endovascular clot removal

    This trial will test whether taking eligible adults with suspected large- or medium-vessel ischemic stroke straight to the angiography suite for imaging and treatment gets clot-removal therapy started faster and improves outcomes.

    Recruiting Paracelsus Medical University · Nuremberg and 1 other locations · NCT07052045

  • Identifying causes of organ failure in critically ill patients

    This study is trying to find out if a specific type of cell death related to iron is causing organ failure in critically ill patients in the ICU, to help develop new treatments in the future.

    Recruiting University Hospital, Antwerp · Edegem · NCT06928649

  • Investigating lung injury after subarachnoid hemorrhage

    This study looks at how lung injury happens after a brain bleed to see if a substance called hyaluronic acid plays a role and to find better treatments for patients aged 18 to 80.

    Recruiting Tianjin Medical University · Tianjin · NCT06628531

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.